Wikisage, the free encyclopedia of the second generation, is digital heritage

Cannabis (drug): Difference between revisions

From Wikisage
Jump to navigation Jump to search
(Crippa et al.)
No edit summary
Line 1: Line 1:
<small>unknown efficacy in [[epilepsy]] </small>
<small>unknown efficacy in [[epilepsy]] </small>
<ref>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5068473/pdf/ndt-12-2605.pdf</ref>
<ref>[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5068473/pdf/ndt-12-2605.pdf]</ref>
<ref>https://www.ncbi.nlm.nih.gov/pubmed/26941559 Is the medical use of cannabis a therapeutic option for children?</ref>
<ref>[https://www.ncbi.nlm.nih.gov/pubmed/26941559 Is the medical use of cannabis a therapeutic option for children?]</ref>


The Cannabis sativa plant contains(<ref>http://www.agriculture.pa.gov/Protect/PlantIndustry/NIPPP/Documents/marijuana%20article.pdf</ref>) more than 400 compounds, of which 100 are known as phytocannabinoids. The two cannabinoids with the highest concentrations in cannabis are delta9-tetrahydrocannabinol (Δ9-THC), responsible for most of the psychotomimetic effects of the drug, and cannabidiol (CBD), the most common non-psychoactive cannabinoid  
The Cannabis sativa plant contains(<ref>http://www.agriculture.pa.gov/Protect/PlantIndustry/NIPPP/Documents/marijuana%20article.pdf</ref>) more than 400 compounds, of which 100 are known as phytocannabinoids. The two cannabinoids with the highest concentrations in cannabis are delta9-tetrahydrocannabinol (Δ9-THC), responsible for most of the psychotomimetic effects of the drug, and cannabidiol (CBD), the most common non-psychoactive cannabinoid  

Revision as of 18:38, 23 December 2016

unknown efficacy in epilepsy [1] [2]

The Cannabis sativa plant contains([3]) more than 400 compounds, of which 100 are known as phytocannabinoids. The two cannabinoids with the highest concentrations in cannabis are delta9-tetrahydrocannabinol (Δ9-THC), responsible for most of the psychotomimetic effects of the drug, and cannabidiol (CBD), the most common non-psychoactive cannabinoid [4]

Links

Cannabinoids for pediatric epilepsy? Up in smoke or real science?

Medical Cannabis

Kolikonda et al. 2016 [5]

Entourage effect

Cannabinoids and Epilepsy

Ben Shabat et al 1998. An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity Eur J Pharmacol.